hydroxyl radical has been researched along with 3,5-dibromotyrosine in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (3,5-dibromotyrosine) | Trials (3,5-dibromotyrosine) | Recent Studies (post-2010) (3,5-dibromotyrosine) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 15 | 1 | 5 |
| Protein | Taxonomy | hydroxyl radical (IC50) | 3,5-dibromotyrosine (IC50) |
|---|---|---|---|
| Receptor-type tyrosine-protein phosphatase alpha | Homo sapiens (human) | 4.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, DM; Glushakov, AV; Gravenstein, N; Martynyuk, AE; Seubert, CN; Sumners, C; Yarotskyy, V | 1 |
1 review(s) available for hydroxyl radical and 3,5-dibromotyrosine
| Article | Year |
|---|---|
Halogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders.
Topics: Animals; Brain; Brain Diseases; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Hydroxyl Radical; Mental Disorders; Neuroprotective Agents; Phenylalanine; Synaptic Transmission; Tyrosine | 2006 |